Stroke, Vol 17, 1068-1070, Copyright © 1986 by American Heart Association
HP Adams Jr
Despite its efficacy in preventing rebleeding, the anticipated strong trend
in favor of early intracranial surgery has not been achieved. Early
intracranial operation remains a useful choice in the management of recent
SAH in good-risk patients, but patients must be carefully selected on an
individual basis. Many patients will undoubtedly benefit from early surgery
but it is not a panacea. Further investigation of surgical treatment in
combination with improved preoperative and postoperative medical therapy
will be required to ameliorate the outcome of SAH. In particular, the
prevention and treatment of cerebral infarction deserves attention. The
results of the antifibrinolytic and timing of intracranial surgery studies
point to the need for an effective prevention treatment regimen for
vasospasm. Further studies about the efficacy of calcium channel blocking
drugs in prevention of ischemia after SAH are needed among patients given
antifibrinolytic drugs or having early operation. All the advances in
treatment are predicated on prompt diagnosis of SAH in good-condition
patients. The medical community needs to maintain a high degree of
vigilance for the diagnosis of SAH in all patients complaining of a new,
unusual or severe headache. Early referral to properly equipped and staffed
medical facilities remains a keystone to effective treatment of SAH.
ARTICLES
Early management of the patient with recent aneurysmal subarachnoid hemorrhage
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |